News

News

Eyam Vaccines and Immunotherapeutics Secures Global Health Grant to Advance Gemini Expression Platform

By |2024-09-10T16:11:22+00:00September 10th, 2024|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Vaccines and Immunotherapeutics Secures Global Health Grant to Advance Gemini Expression Platform

Eyam Announces Nicholas Franco Appointment to Board of Advisors

By |2024-06-24T16:43:33+00:00June 24th, 2024|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Announces Nicholas Franco Appointment to Board of Advisors

Eyam Welcomes Wolfgang Koester to Board of Directors

By |2024-03-18T21:08:29+00:00March 18th, 2024|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Welcomes Wolfgang Koester to Board of Directors

Eyam Announces Artificial Intelligence Research Facility in Partnership with Mitacs

By |2023-05-31T18:37:56+00:00May 31st, 2023|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Announces Artificial Intelligence Research Facility in Partnership with Mitacs

Eyam Announces Partnership with Mitacs to Fund Next Generation COVID-19 Vaccine Technologies

By |2022-10-11T16:06:51+00:00October 11th, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Announces Partnership with Mitacs to Fund Next Generation COVID-19 Vaccine Technologies

Eyam Acquires Option for Novel Antibody Biologic Therapeutics for the Treatment of Leukemia and Lymphoma

By |2022-10-07T16:04:15+00:00September 27th, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Acquires Option for Novel Antibody Biologic Therapeutics for the Treatment of Leukemia and Lymphoma

Eyam Vaccines And Immunotherapeutics Embarks On New Licensing Agreement For Creating Innovative Vaccine Technologies

By |2022-10-04T16:16:21+00:00August 3rd, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam Vaccines And Immunotherapeutics Embarks On New Licensing Agreement For Creating Innovative Vaccine Technologies

Eyam’s Chief Scientific Officer, Dr. Wilfred Jefferies, Inducted in the National Academy of Inventors

By |2022-06-15T22:21:33+00:00June 15th, 2022|News|

Over the last several months, it seems like we’ve been on a COVID-19 Rollercoaster. First, the long-awaited vaccines rolled out and a subsequent decline in cases was reported in regions where vaccines were rolled out quickly.

Comments Off on Eyam’s Chief Scientific Officer, Dr. Wilfred Jefferies, Inducted in the National Academy of Inventors
Go to Top